Gryphon Bio, Inc. has announced its pursuit of observational clinical studies with partners at multiple U.S. and ...
IGC Pharma, Inc. ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease has been officially named CALMA (Calming Agitation in Alzheimer's).
About Neurogen Biomarking Neurogen Biomarking is dedicated to supporting early detection of Alzheimer’s disease and Mild Cognitive Impairment. Founded by award-winning neurologist, Dr. Rany ...
Advanced brain-on-a-chip technology developed by EU-funded researchers helps make potential treatments for neurological ...
Cambridge, USA-based biotech Sunbird Bio, which is developing proprietary blood-based technologies to improve diagnosis and ...
TEL AVIV, Israel, Jan. 07, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage ...
Local events from Jan. 21-24 will honor Martin Luther King Jr. See what you can do on Monday, MLK Day, at the Toledo Museum ...
Fauna Bio, a biotechnology company improving human health by leveraging ... Mary Alexander & Associates filed a second lawsuit against disgraced Dr. William Moore Thompson and Hoag Memorial Hospital ...
We are now seeing in the data what we suspected about blarcamesine for a long time – that it has the potential to make a clinical difference for people living with early Alzheimer’s disease,” said ...
The region has seen several young companies rocket to success in recent years, and these 10 startups look ready to fire up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback